PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 420 of 684

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07221227: A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07167940: Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07106021: A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07074977: Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07061977: Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07025811: A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07018323: A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06931821: Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06771050: ROADMAP Clinical Trial

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06654869: Effects of Laughter Yoga on Symptom Severity, Hope, and Life Engagement in Patients Undergoing Chemotherapy; A Randomized Controlled Study

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06629493: Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06395103: Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06388642: Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06184750: Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06129539: A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05754749: Comparison of CE-DBT and MRI in Patients With Known Breast Lesions

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05616624: ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05556824: Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05552157: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05318521: RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05209633: Efficacy and Safety of Using Granules Dendrobii for the Treatment of Chronic Atrophic Gastritis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05109429: Developing a Clinical Outcome Assessment for Opioid Craving

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04951622: A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04523922: Oxytocin to Enhance Integrated Treatment for AUD and PTSD

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04045470: A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04012944: SIRONA 2 Trial Heart Failure NYHA Class III

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02505386: Pharmacokinetics of Ertapenem in Patients Aged Over 75

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01810913: Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene Apologizes for TG-C Clinical Trial Failure... Vows to Regain Honor as World's First Therapy

아시아경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Syntara Secures FDA Support for Amsulostat Phase 2b Trial in Myelofibrosis and Raises $8M to Fuel Clinical Pipeline Growth

Kalkine MediaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Syntara's FDA-Backed Amsulostat Advances to Phase 2b Myelofibrosis Trial as Clinical Pipeline Delivers Multiple Data Catalysts

KalkineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grand Pharmaceutical Group Limited Revenue Breakdown – FWB:MX6A

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tien Liang Biotech Co., Ltd. Revenue Breakdown – TPEX:4127

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[The Paradox of the KOSDAQ Promotion & Relegation System]② Technology Transfer Performance Requirement? ...Risk of Accelerating Early Technology Outflow

아시아경제Original source
🌍discoverynews.google.comTier 2 · Trade media

Crystalys Therapeutics Tacks On $130M for Pivotal Tests of Gout Drug

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dimerix to Present Phase 3 FSGS Trial Update and Acute Kidney Injury Program at TechKnow Invest Conference

KalkineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Patrys Reformulates Proven Quetiapine Drug for Rapid Injectable Treatment of Delirium in ICU Patients

KalkineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda (TSE:4502) Stock Looks Below Fair Value While Broader Checks Stay Mixed

Yahoo Finance SingaporeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Breaking: World’s Largest Pharmaceutical Company, Eli Lilly, Acquires 5-MeO-DMT Developer AtaiBeckley for Up to $3.8 billion

Psychedelic AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fred Ramsdell: Biotech is ‘leading innovative science, not universities’

Times Higher EducationOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Samchundang tempers FDA hope as Korea weighs disclosure rules and GMP woes - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FSS scrutinizes Samchundang as FDA path hinges on BE claims and factory checks - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viking Therapeutics (NASDAQ:VKTX) Stock in Focus Ahead of Cash-Burn Scrutiny, Earnings Set for July 29

TechStock²Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Anhui Sunhere Pharmaceutical Excipients Co., Ltd. Class A – SZSE:300452

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cyclospora outbreak: Former FDA food safety chief says skip this lettuce

NewsweekOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

JiangXi Tianxin Pharmaceutical Co., Ltd. Class A Revenue Breakdown – SSE:603235

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Enwei Pharmaceutical Co., Ltd. Class A – SZSE:301331

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IDG SEIZES PHP 700K UNREGISTERED KOREAN LUNCHEON MEAT IN CEBU

United News PhOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Laminar Pharma Completes Pivotal Phase 2b/3 Trial of LAM561 in Newly Diagnosed Glioblastoma

BioPharma APACOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PRNAF SEC Filings - ALTERITY THERAPEUTICS LTD 10-K, 10-Q, 8-K Forms

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Anhui Sunhere Pharmaceutical Excipients Co., Ltd. Class A – SZSE:300452

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nunzia Pharmaceutical Corporation Revenue Breakdown – OTC:NUNZ

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA suspends licences of three Mumbai hotels over food safety breaches

The News MillOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune FDA Raids: Butter Shortage Looms for Restaurants

The Chenab TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Trump Administration’s Best Healthcare Idea Isn’t the One Getting Attention

Daily SignalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Compounded GLP-1 drugs creating concern among doctors and FDA

NewsNationOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Universal Gene Synthesis Screening Protects American Biotech

American Enterprise Institute - AEIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

The Globe and MailOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chugai Pharmaceutical (TSE:4519) Stock Net Margin Strength Challenges Cost Pressure Concerns

simplywall.stOriginal source